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Actin cytoskeletonWiskott–Aldrich Syndrome (WAS) is caused by mutations in Wiskott-Aldrich Syndrome Protein (WASP) and
majority of the mutations are found in the WASP Homology 1 (WH1) domain which mediates interaction with
WIP (WASP Interacting Protein), a WASP chaperone. Two point mutations together in the proline rich region
(PRR) domain of WASP (S339Y/P373S) have been reported to cause WAS however the molecular defect has not
been characterized. Expression of these mutants separately (WASPRS339Y, WASPRP373S) or together (WASPRSP/YS) did
not rescue the chemotaxis defect or membrane projection defect of JurkatWKD T-cells (WASP knockdown). This
is not due to the inability of WASP-PRR mutants to form functional WASP–WIP complex in growth rescue experi-
ments in las17Δ yeast strain. Expression ofWASPRS339Y but notWASPRP373S orWASPRSP/YS rescued the IL-2 expression
defect of JurkatWKD T-cells, suggesting that Pro373Ser mutation alone is sufﬁcient to inhibit WASP functions in T-
cell activation. The diffused localization of WASP-PRR mutants in activated Jurkat T-cells suggests that Ser339
and Pro373 are critical for WASP localization. WASP-PRR mutations either together or individually did not abolish
interaction ofWASPwith sixteenWASP binding proteins includingHck, however they caused reduction inHckme-
diated tyrosine phosphorylation of WASP which is critical for WASP activity. The auto-inhibitory conformation of
WASPP373Smutantwas not relieved by the binding of Toca-1 or Nck1. Thus, our results suggest that Pro373Sermu-
tation reduces Tyr291 phosphorylation and prevents conformational changes required forWASP activity in chemo-
taxis and T-cell activation. Thus Pro3373Ser is probably responsible for all the defects associated with WAS in the
patients.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Wiskott–Aldrich Syndrome (WAS) is anX-linked immunodeﬁciency
disorder characterized by eczema, bloody diarrhea and recurrent infec-
tions [1,2]. The gene mutated in the syndrome was identiﬁed by posi-
tional mapping and subsequently cloned [3]. Identiﬁcation of the gene
led to the discovery that mutation in this gene also gives rise to other
two related disorders, X-linked thrombocytopenia (XLT) [4] and X-
linked neutropenia (XLN) [5]. WASP is expressed predominantly in
cells of hematopoietic lineage [6]. T-cells fromWAS patients are charac-
terized by fewer microvilli like projections, defects in chemotaxis and
failure to proliferate upon activation [7–9].WASP knockoutmouse is vi-
ablewith defects in T-cell activation [10,11]. All these aremanifestations
of a defective cytoskeleton [12].
WASP gene encodes a proline rich adaptor proteinWASP,with several
functional domains;WASPhomology 1 (WH1) domain at theN-terminal
followed by a basic region (BR), a GTPase binding domain (GBD), a pro-
line rich sequence and a Verprolin homology, Coﬁlin homology, and
Acidic region (VCA) domain at the C-terminus [13]. The N-terminal6791 3856.
).
ights reserved.WH1 domain (aa 1–138) mediates interaction with the verprolin family
of proteins (WIP,WIRE and CR16) [14]while the C-terminal VCA domain
activates the actin nucleation activity of Arp2/3 complex [13,15].
A largenumber ofmissensepointmutations inWASPhave been iden-
tiﬁed from patients with different degrees of severity such as Wiskott–
Aldrich Syndrome (WAS), X-linked thrombocytopenia (XLT) and X-
linked neutropenia (XLN) [16,17]. However the links betweenmutations
and disease have not been characterized. Majority of themissensemuta-
tions in WASP are located in the WH1 domain of WASP [17], the region
important for interaction with WASP interacting protein (WIP) [6].
Some of the missense mutations in the WH1 domain of WASP have
been shown to affect WASP–WIP interaction [18,19]. WIP is a chaperone
for WASP and loss of interaction withWIP leads to the proteolytic cleav-
age ofWASP andWASP deﬁciency [20]. Out of 52WASPmissense muta-
tions reported [17], 12 missense mutations are present outside theWH1
domain and 5 mutations causing classic WAS in humans are located in
the proline rich region (PRR) (S339Y/P373S), the WASPbase [21] and
the VCA domain (P459S, K476E and D485N) of WASP [17].
WASP has been shown to adopt a closed inactive conformation due
to intra-molecular interaction between the acidic region of the VCA do-
main and the basic region adjacent to the GBD [22].We have previously
used bimolecular complementation assay to show that the closed con-
formation of WASP is stabilized by WIP [23]. This closed conformation
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Proline rich region ofWASP is crucial for localization ofWASP to the im-
munological synapse [24] and has been shown to interact with the SH3
domain of tyrosine kinases and adaptor proteins [17,25]. However the
molecular defect caused by mutation in the proline rich region of
WASP has not been identiﬁed. Characterizing the molecular defect of
mutations (WASPP373S, WASPS339Y) at proline rich region of WASP will
lead to a better understanding of the regulation ofWASP by SH3domain
containing proteins.
In this study we generated a WASP knockdown Jurkat T-cell
(JurkatWKD) and found the JurkatWKD T-cells to have reduced migration
velocity, defective chemotaxis, and defective upregulation of IL-2
transcription. Expression of WTWASP rescued all the defects while ex-
pression of WASPP373S or WASPPS/SY did not rescue any of the defects of
the JurkatWKD T-cells. Expression of WASPS339Y rescued the IL-2
transcription defect of JurkatWKD T-cells but not the chemotaxis defect.
Conformational analysis suggests that WASPP373S adopts a closed con-
formation just like the WTWASP but unlike WT WASP the closed con-
formation of WASPP373S was not relieved in the presence of Toca1 or
Nck1 even though both Toca1 and Nck1 can bind to WASPP373S.2. Materials and methods
2.1. Yeast strains, media, cell lines, reagents and antibodies
Saccharomyces cerevisiae strain PJ69-4A was used for yeast two hy-
brid assay and IDY166 [26] was used for growth rescue experiment.
YPUAD (yeast extract, peptone, uracil, adenine and dextrose) media
was used for yeast cell culture. Jurkat (clone E6-1) (ATCC, USA) was
maintained in RPMI media supplemented with 10% FBS and 1% penicil-
lin/streptomycinwhile Phoenix Amphotropic packaging cell line (ATCC,
USA) was maintained in DMEM with 10% FBS at 37 °C CO2 incubator.
Anti-human CD3 clone OKT3 and CD28 clone CD28.2 were purchased
from eBioscience. Alexa Fluor 488 and 594 phalloidin were fromMolec-
ular Probes. G418-sulfate and SDF-1α were from PAA Laboratories and
PeproTech respectively. Mouse monoclonal anti-WASP (D1), anti-
Cdc42 and anti-GAPDH antibodies were from Santa Cruz and Ambion
respectively. Mouse anti-phosphotyrosine clone-4G10 was purchased
from Upstate Biotechnology (Lake Placid, NY, USA). Anti-His antibody
was purchased from Delta Biolabs. All secondary antibodies conjugated
with horseradish peroxidase were from Sigma-Aldrich (St. Louis, MO,
USA).2.2. Site-directed mutagenesis
QuickChange Site-Directed Mutagenesis kit from Stratagene
(La Jolla, CA, USA) or Overlap Extension technique was used to gen-
erate the mutation of interest at speciﬁc locations in the human
WASP cDNA sequence and cloned in EBV based plasmid and WASP
promoter was used for the transcriptional regulation of WASP
expression.2.3. Retrovirus vector mediated RNAi
Phoenix Amphotropic cell line was used to generate retroviral parti-
cles. In brief, Amphotropic cells were transfected with 80 μg of plasmid
encodingWASP speciﬁc shRNA (S1-WASP shRNA) (GCAGGGAATTCAGC
TGAACAA) under the transcriptional control of U6 promoter and GFP
under the CMVpromoter using calciumphosphate transfectionmethod.
48 h of post-transfection, cell supernatant was collected and used to
transduce Jurkat T-cells. The transduced Jurkat T-cells stably expressing
GFP were sorted using FACS Aria and further grown before analysis of
endogenous WASP expression.2.4. Stable transfection
Four silent mutations were introduced in WASP gene in the region
targeted by S1-WASP shRNA (GCAAGGTATCCAACTGAACAA) thusmak-
ing it resistant (WASPR) to the silencing machinery. Gene transfections
in Jurkat T-cells were performed using Neon transfection system
(Invitrogen, CA, USA) according to manufacturer's instructions. In
brief, JurkatWKD T-cells were microporated (three pulses with pulse
width of 10 ms at 1500 V) with 10 μg of WASPR (WT or mutants) ex-
pressing plasmid. The cells were selected with neomycin (1.5 mg/ml)
(G-418) for a period of one week. Stable expression of exogenous
gene was conﬁrmed by Western blotting.
2.5. Fluorescence visualization of yeast cells
Conformational analysis of WASP or its mutants was performed
using Bi-molecular Fluorescence Complementation (BiFC) assay as
described previously [23]. In brief, cells grown to exponential
phase were harvested at 600 ×g for 5 min. They were washed
twice with PBS, resuspended in PBS and applied to a microscope
slide. Fluorescence imaging was performed using an Olympusmicro-
scope with CoolSNAPHQ camera (Roper Scientiﬁc). Quantiﬁcation of
ﬂuorescence intensities of 100 cells was performed using the
MetaMorph software (Molecular Devices, CA, USA). The growth res-
cue experiment was performed as described previously [19].
2.6. Cell migration assays
Chemotaxis of migrating cells in a gradient of SDF-1αwas observed
using Dunn chamber (Weber Scientiﬁc International; [27]). In this
assay, 2.25 × 106 Jurkat T-cells attached to the ﬁbronectin (2 μg/ml)
coated coverslip were placed onto Dunn chamber ﬁlled with complete
RPMI media. The outer well media was then replaced with media con-
taining chemokine (SDF-1α, 5 nM) and subsequently, the edges of the
coverslip were sealed with a mixture of hot wax (1:1:1, parafﬁn wax,
bees wax and vaseline). The cell migration on annular bridge between
the outer and the inner well was observed and captured at 2 min inter-
val for a period of 3 h using an inverted microscope (Olympus IX81) at-
tached to the CoolSNAPHQ camera. The migration tracks were analyzed
using MetaMorph software (Molecular Devices, CA, USA) and plotted.
Chemotaxis was also assessed by transwell migration assay using poly-
carbonatemembrane insert, 24well transwell (5 μmpore size) (catalog
no—3421). 2 × 105 Jurkat T-cells or JurkatWKD T-cells expressing WT
WASP or its mutants were added to the upper well of transwell and
allowed to migrate towards the chemokine (SDF-1α, 100 ng/ml) con-
taining RPMI media in lower well for 3 h. Cells migrated to the lower
well were counted and percentages of cells migrated were plotted.
2.7. IL-2 expression assay
JurkatWKD T-cells expressingWASP ormutantswere stimulatedwith
wells coated with anti-human CD3/CD28 (2 μg/ml each) for 8 h. Total
RNAwas isolated (Omega Bio-Tek) and converted into cDNA. Quantita-
tive real timePCR for IL-2 gene expressionwas performed using thermal
cycler (Applied Biosystem7500) and SYBRGreen/ROXqPCRMasterMix
(Fermentas). The sense and anti-sense primers for IL-2 expression are
(in 5′–3′ direction) CAAACCTCTGGAGGAAGTGCT, and AATGGTTGCTGT
CTCATCAGC. Real time speciﬁc primers for human MRPL-27 (CTGGTG
GCTGGAATTGACCGCTA and CAAGGGGATATCCACAGAGTACCTTG)
were used for normalization.
For IL-2 cytokine secretion analysis in culture media, JurkatWKD T-
cells expressing WASP or mutants were resuspended in complete
RPMI media at 1 × 106 cells/ml containing both mouse anti human
CD3 and CD28 (2 μg/ml each) and incubated on ice for 45 min. Cells
after incubation were washed and plated on 96 well plate pre-coated
with anti-mouse IgG Ab (for cross-linking) (10 μg/ml). Supernatant
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IL-2 by standard ELISA (PeproTech Human IL-2 kit, 900-K12).
2.8. Immunoﬂuorescence microscopy and localization
Stable WASP or WASP mutants expressing JurkatWKD T-cells were
seeded on anti-CD3/anti-CD28 (2 μg/ml each) antibody coated cover-
slip and incubated for 30 min in humiﬁed CO2 incubator. Cells were
ﬁxedwith 4% formaldehyde for 20 min,washed three times and stained
with Alexa Flour 594 phalloidin. Themean surface area (in μm2) and av-
erage number of membrane projections per cell of 30 cells from each
populationwere calculated usingMetaMorph software. The experiment
was repeated thrice and 30 cellswere evaluated in each set of the exper-
iment. Localization study of WASP or its mutants in WT Jurkat T-cells
relative to actin was performed as described [28]. In brief, WASP or its
mutants (tagged with RFP) expressing cells were seeded on anti-CD3
coated (10 μg/ml) coverslip and incubated for 5 min. Coating of cover-
slip with antibodies was performed overnight at 4 °C. Poly-L-lysine
coated coverslip was used as control. Cells after incubation were ﬁxed
with 4% formaldehyde in PBS, washed thrice with PBS and stained
with Alexa Flour 488 phalloidin. Fluorescent images were captured
using Olympus microscope ﬁtted with CoolSNAPHQ2 camera.
2.9. T-cell–APC conjugate formation
Raji B-cells were stained with CMAC (Molecular Probes) for 30 min
and then incubated with 2 μg/ml of SEE superantigen (Toxin Technolo-
gies) for 90 min at 37 °C. B- and T-cells in equal number were mixed
and incubated for 30 min at 37 °C. Cells after incubation were plated
on poly-L-lysine coated slides and allowed to adhere for 10 min. Cells
on the slide were ﬁxed with 3.7% formaldehyde and stained with
phalloidin 488 for F-actin staining.
2.10. Statistical analysis
Data represent in all the experiments as the mean ± s.e.m. from
three independent experiments. Statistical signiﬁcance analysis was
determined using unpaired Student's t-test. P b 0.05 was considered
statistically signiﬁcant.
3. Results
3.1. WASP-PRR mutants do not rescue chemotaxis defect of JurkatWKD
T-cells
We have previously characterized 52 missense mutations in WASP
using yeast mutant strain and found that 13 mutations out of 40 muta-
tions in the WH1 domain affected the activity of WASP–WIP complex
and none of the 12mutations outside theWH1 domain affected the ac-
tivity of the WASP–WIP complex [19]. Two mutations (S339Y/P373S)
together in the proline rich region ofWASP have been found inWAS pa-
tients, WASPbase [17,21]. However it is not known whether both the
mutations are required to compromise the activity of WASP or what
are the molecular defects caused by these mutations.
In order to analyze the effect of the mutations on the activity of
WASP we generated JurkatWKD T-cells (WASP knockdown Jurkat T-
cells) using WASP speciﬁc shRNA (S1-shWASP). We generated retrovi-
rus expressing S1-shWASP under the transcriptional regulation of U6
promoter and EGFP under transcriptional regulation of CMV promoter.
Jurkat T-cells were infected with the retrovirus using spinoculation
and subsequently the infected cells were FACS sorted using GFP ﬂuores-
cence. The FACS sorted cells were cultured and the expression of WASP
was analyzed by immunoblotting with anti-WASP antibody, which
showed a signiﬁcant knockdown of WASP expression as determined
by Western blotting and 50% knockdown as determined by qPCR
(data not shown). We used WASPR, resistant to the S1-shWASP toanalyze the function of mutants in JurkatWKD T-cells and tagged it
with RFP to distinguish between the endogenousWASP and exogenous
WASP constructs. Plasmids (neomycin resistant) expressing WASPR or
itsmutants (WASPRS339Y orWASPRP373S orWASPRSP/YS)weremicroporated
in JurkatWKD T-cells and selected with neomycin (G418) for one week
which enabled to get more then 90% of cells expressing the exogenous
gene (data not shown). The JurkatWKD T-cells expressing WASPR
constructs were assayed for chemotaxis using Dunn chamber with
SDF-1α as a chemo-attractant. The migration of cells in annular bridges
was recorded using time-lapse microscopy over a 3 h period.
JurkatWKD T-cells migrated slower than Jurkat T-cells (data not
shown) and expression of WASPR restored the migration velocity of
JurkatWKD T-cells while expression of RFP (control) did not (Fig. 1B, C).
The migration speed of JurkatWKD T-cells expressing WASPRS339Y
(1.73 μm/min), WASPRP373S (1.96 μm/min) or WASPRSP/YS (1.75 μm/min)
was similar to JurkatWKD expressing WASPR (2.17 μm/min) while
JurkatWKD T-cells expressing RFP alone (control) had a reduced velocity
(0.85 μm/min) (Fig. 1B, C) suggesting thatWASPmutants are able to res-
cue themigration speed of JurkatWKD T-cells. The overall directionality of
the cell motility was analyzed by plotting circular histograms which
showed that 77% of total JurkatWKD T-cells expressing WASPR moved to
a position within the 40° arc facing the chemokine source whereas
only 20% of the total JurkatWKD (WASPRS339Y) T-cells moved to within
the 40° arc facing the chemokine source which was similar to the RFP
(22%) expressing cells. About 30% of total JurkatWKD (WASPRP373S) T-
cells and only 20% of total JurkatWKD (WASPRSP/YS) T-cells migrated to
the 40° arc facing the chemokine source, indicating that mutations in ei-
ther of the residues affected the ability ofWASPR to rescue the chemotax-
is defect of JurkatWKD T-cells (Fig. 1C, D). Chemotactic defect observed in
JurkatWKD T-cells expressingWASPRS339Y or WASPRP373S or WASPRSP/YS was
not due to poor expression of respectiveWASPmutant proteins asWest-
ern blot analysis showed that their expression was comparable to
WASPR expression (Fig. 1E).
In order to conﬁrm the chemotactic defect of JurkatWKD T-cells ex-
pressing WASPR-PRR mutants towards SDF-1α, a transwell migration
assay was performed. Similar to chemotactic defects observed in Dunn
chamber, the migration of JurkatWKD T-cells expressing WASP mutants
was signiﬁcantly impaired in transwell migration assay (40.0% of total
JurkatWKD (WASPRS339Y) T-cells, 40.3% of total JurkatWKD (WASPRP373S)
T-cells, 39.10% of total JurkatWKD (WASPRSP/YS) T-cells migrated towards
SDF-1α containing media in lower well compared to 51.24% of
JurkatWKD (WASPR) T-cells) (Fig. 1F). Thus the data suggest that the ex-
pressions ofWASPmutants (WASPRS339Y orWASPRP373S orWASPRSP/YS) do
not rescue the chemotaxis defect of JurkatWKD T-cells towards chemo-
kine SDF-1α. These results suggest a possible molecular defect giving
rise toWiskott–Aldrich Syndrome in patients withWASPSP/YS mutation.
3.2. WASP-PRR mutants do not rescue the membrane projection defect of
JurkatWKD T-cells
WASP is required for formation of actin rich membrane projections
(microvilli) as lymphocytes from WAS patients were found to have
fewermicrovilli, although it did not affect the expression of various sur-
face receptors [9,29]. Similarly, WASP-deﬁcient B-cells are defective in
ﬁlopodia extension in response to bradykinin stimuli [30] suggesting
that WASP plays an important role in regulatingmembrane projections
in hematopoietic cells. Thus, to analyze the effect of theWASP-PRRmu-
tations on WASP mediated actin cytoskeleton organization, JurkatWKD
T-cells expressing WASPR or its mutants (WASPRS339Y, WASPRP373S,
WASPRSP/YS) were stimulated for 30 min on anti-CD3/anti-CD28 coated
plates. The cells were ﬁxed, permeabilized and stained with Alexa 594
phalloidin. All the WASP-PRR mutants expressing JurkatWKD T-cells
spread well on anti-CD3/anti-CD28 coated plates and formed circular
actin ring (Fig. 2A, B), but formed signiﬁcantly fewermembrane projec-
tions compared to WASPR expressing cells (Fig. 2C) suggesting that the
inability of WASPmutants to rescue the chemotaxis defect of JurkatWKD
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Fig. 2. JurkatWKD T-cells expressingWASP-PRR mutants were defective in actin cytoskeleton organization upon anti-CD3/anti-CD28 stimulation. A) JurkatWKD T-cells expressing (1) RFP,
(2) WASPR-RFP, (3)WASPRS339Y-RFP, (4)WASPRP373S-RFP, and (5)WASPRSP/YS-RFP were stimulated on anti-CD3/anti-CD28 (2 μg/ml each) antibody coated coverslip for 30 min, ﬁxedwith
3.7% formaldehyde and stained with Alexa 594 phalloidin. Bar = 5 μm. B) The average surface area of total 90 randomly chosen cells (30 cells in each set of three independent experi-
ments) was quantiﬁed using MetaMorph software and plotted. C) The average number of membrane projections per cell was quantiﬁed at a total of 90 randomly chosen cells (30 cells
in each set of three independent experiments). **P b 0.01, compared to JurkatWKD T-cells expressing RFP (unpaired Student's t-test).
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ulate the actin cytoskeleton reorganization.
3.3. WASP-PRR mutants exhibit diffused localization at immunological
synapses
The proline rich region ofWASP has been shown to be important for
WASP recruitment to the TCR contact sites [25]. Thus, the localization of
WASP and its mutants was analyzed using Jurkat T-cells expressing
WASPR-RFP (WT or mutants) under the transcriptional regulation of
CMV promoter. In order to study the localization pattern of WASP-PRR
mutants relative to actin during TCR stimulation, JurkatWT T-cells ex-
pressing WASPR-RFP or mutants (WASPRS339Y-RFP or WASPRP373S-RFP or
WASPRSP/YS-RFP) were stimulated on anti-CD3 antibody coated plate
for 5 min (at this time point, cell spreading was maximal and cells
form the strongest contact with the stimulatory plane). Cells were
ﬁxed and stained with Alexa 488 phalloidin. This localization study of
WASP during T-cell activation is based on a published method [28]
and JurkatWT T-cells were used as JurkatWKD T-cells express GFP; there-
fore, it could not be used for co-localization studies. In the absence of
anti-CD3 (on poly-L-lysine coated surface), Jurkat T-cells were notFig. 1. JurkatWKD T-cells expressing WASP-PRR mutants were defective in chemotaxis towards
JurkatWKD T-cells using anti-WASP antibody and anti-GAPDH (loading control). B) Average velo
WASPRSP/YS-RFP. The velocity of sixty cells, 20 cells from each set from 3 independent experimen
(unpaired Student's t-test). C)Migration paths of 20 randomly chosen cells shown in the formof ve
andWASPRSP/YS-RFP in Dunn chamber assay. Imageswere captured using time-lapsemicroscopy fo
each cell and the source of SDF-1α is at the top. D) Circular histogram representing the overall
concentration of chemokine (SDF-1α) source was plotted for 60 randomly chosen cells in Dunn
WASPRP373S-RFP, andWASPRSP/YS-RFP was analyzed by Western blot using anti-WASP antibody a
(3) WASPRS339Y-RFP, (4) WASPRP373S-RFP, and (5) WASPRSP/YS-RFP were allowed to migrate for 3 h t
of cellsmigratedwas calculated as the number of cellsmigrated to the bottomwell to the initial cel
to JurkatWKD T-cells expressing RFP (unpaired Student's t-test).spread well and localization of WASP was observed throughout the
T-cell cytoplasm (Fig. 3A). However, Jurkat T-cells spread well on
anti-CD3 coated surface and WASP was co-localized with actin ring
at the periphery of the spread cell (Fig. 3A). There was no co-
localization of WASPRS339Y-RFP with polymerized actin ring at
the periphery of the fully spread cell (Fig. 3A). Small patches of
WASPRS339Y-RFP were observed inside the cell. Studies of cells ex-
pressing WASPRP373S-RFP or WASPRSP/YS-RFP showed that the localiza-
tion of these mutants with actin ring was partially impaired (and
most of thesemolecules were located inside the cell in a diffused pat-
tern) (Fig. 3A). Further we next examined the localization pattern of
WASP or its PRR mutants in Jurkat T-cells conjugated to Raji B-cells
pulsed with SEE toxin. In the conjugate in the presence of SEE pulsed
Raji B-cells, WASPR-RFP was localized at the T:B cell–cell contact site
and it co-localized with actin. However, WASP mutant (WASPRS339Y-
RFP) was not accumulated at the T:B contact site and it localized in
the form of small patches inside the Jurkat T-cell (Fig. 3B). WASPRP373S-
RFP orWASPRSP/YS-RFPwas localized in a diffused pattern in T:B cell con-
jugates (Fig. 3B), thus suggesting that missense mutation in the PRR of
WASP causingWAS affected the localization ofWASP at the TCR activa-
tion site.SDF-1α. A) Western blot analysis of expression of endogenousWASP in Jurkat T-cells and
city of JurkatWKD T-cells expressing RFP, WASPR-RFP,WASPRS339Y-RFP, WASPRP373S-RFP, and
tswas used to calculate themean. **P b 0.01 compared to JurkatWKD T-cells expressing RFP
ctor plot from JurkatWKD T-cells expressing RFP,WASPR-RFP,WASPRS339Y-RFP,WASPRP373S-RFP,
r 3.0 h at 2.0 min intervals. X and Y axis intersection pointswere taken as the starting point of
directionality of migration (ﬁnal position of cells lie in 20° sector) towards the increasing
chamber assay. E) Cell lysate of JurkatWKD cells expressing RFP, WASPR-RFP, WASPRS339Y-RFP,
nd anti-GAPDH (loading control). F) JurkatWKD T-cells expressing (1) RFP, (2) WASPR-RFP,
owards SDF-1α (100 ng/ml) containing media in the bottomwell of a transwell. Percentage
l number loaded to the upperwell. The experimentwas repeated thrice. **P b 0.01 compared
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Fig. 3.WASP-PRRmutants have diffuse pattern of localization at TCR activation site and immunological synapse. A) Jurkat T-cells expressing RFP,WASPR-RFP,WASPRS339Y-RFP,WASPRP373S-
RFP, and WASPRSP/YS-RFP were plated on anti-CD3 (clone OKT3) antibody coated coverslip and poly-L-lysine coated plates. The cells were incubated at 37 °C for 5.0 min, ﬁxed with 3.7%
formaldehyde for 20 min and stained with Alexa 488 phalloidin. B) Jurkat T-cells expressing RFP, WASPR-RFP, WASPRS339Y-RFP, WASPRP373S-RFP, and WASPRSP/YS-RFP were allowed to
form conjugate with Raji B-cells pulsed with SEE toxin, plated on poly-L-lysine coated slides, ﬁxed and stained with phalloidin 488 for F-actin staining. Bar = 5 μm.
628 N. Jain et al. / Biochimica et Biophysica Acta 1842 (2014) 623–6343.4. Expression ofWASPR
P373S orWASPR
SP/YS mutants does not rescue the IL-2
expression defect of JurkatWKD T-cells
T-cells fromWiskott–Aldrich Syndrome patients have defect in IL-2
production in response to TCR stimulation [31]. In order to determine
whether WASP mutants (WASPRS339Y, WASPRP373S, WASPRSP/YS) regulate
IL-2 gene transcription, JurkatWKD T-cells expressing WASPR or its mu-
tants (WASPRS339Y, WASPRP373S or WASPRSP/YS) or RFP alone (control)
were plated on anti-CD3/anti-CD28 (2 μg/ml each) coated plate andincubated for 8 h. RNA from these cells was isolated and used for quan-
titative real-time PCR to check for IL-2 gene expression.
Expression of exogenous WASPR or WASPRS339Y in JurkatWKD T-cells
rescued the IL-2 gene transcription defect (behaved similar to JurkatWT
T-cells, Fig. S1) while the expression of WASPRP373S or WASPRSP/YS mu-
tants was unable to rescue the IL-2 gene transcription defect of
JurkatWKD T-cells (behaved similar to JurkatWKD T-cells) (Fig. 4A). Im-
pairment in IL-2 expression in WASPRP373S or WASPRSP/YS mutants ex-
pressing JurkatWKD T-cells was further conﬁrmed by IL-2 ELISA
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Fig. 4. WASP mutation, Pro373Ser abolished WASP mediated IL-2 gene expression.
A) JurkatWKD T-cells expressing RFP, WASPR-RFP, WASPRS339Y-RFP, WASPRP373S-RFP,
and WASPRSP/YS-RFP were induced for 8 h on stimulatory surface (anti-CD3/anti-
CD28 antibodies coated well; 2 μg/ml each). Total RNA was isolated, converted into
cDNA and used to perform quantitative real time PCR for IL2 gene transcription. B)
Cell culture supernatants from JurkatWKD T-cells expressing RFP, WASPR-RFP,
WASPRS339Y-RFP, WASPRP373S-RFP, and WASPRSP/YS-RFP (stimulated for 24 h with anti-CD3/
CD28 along with cross-linking antibody) were collected and analyzed for IL-2 secretion
by standard ELISA kit. **P b 0.01; ***P b 0.001 compared to JurkatWKD T-cells expressing
RFP (unpaired Student's t-test).
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point mutation (WASPP373S) either alone or together with WASPS339Y
(WASPSP/YS) did not rescue the IL-2 expression defect of JurkatWKD T-- +            - +           
WASP WASPS339Y           
24˚C 37˚CA)
B)
Fig. 5.WASP-PRRmutants suppressed the growth defects of las17Δ cells. A) Las17Δ yeast strainw
with either empty vector or plasmid expressingWIP. The transformants were streaked on YPUAD
transformants in panel A was analyzed by Western blot using anti-WASP antibody and anti-Hexcells, suggesting that P373S mutation alonewas sufﬁcient for inhibiting
WASP function in IL-2 expression. This result also suggests that the
S339Ymutation inWASP does not impairWASP function in IL-2 expres-
sion in Jurkat T-cells.
3.5. WASP proline rich region mutations (S339Y or P373S) do not affect the
interaction with known WASP binding proteins
The proline rich region of WASP has been shown to interact with a
number of SH3 domain containing proteins (tyrosine kinases and adap-
tor proteins) which regulate WASP activation [17,32,33]. Tyrosine
kinases activate WASP through tyrosine phosphorylation (Tyr291) and
destabilize WASP auto-inhibited conformation [34,35]. The two point
mutations (Ser339Tyr and Pro373Ser) in the PRR of WASP may affect
the interaction of WASP with SH3 domain containing proteins.
In order to identify the effect of mutation on WASP–SH3 domain
interaction a yeast two hybrid assay was performed using Gal4BD–
WASP1–503 (WT, WASPS339Y, WASPP373S, WASPSP/YS) or Gal4BD–
WASP306–407 (WT, WASPS339Y, WASPP373S, WASPSP/YS) as bait with
Gal4AD–SH3 domain fusion constructs (Fyn, Fgr, Lyn, Hck, Src, Tec,
Lck, Btk, PI3K, Abl, Nck1, Grb2, Toca-1, Irsp53, Cortactin, PSTPIP) was
used as prey. The two WASP-PRR missense mutants individually
(WASPS339Y orWASPP373S) or together (WASPSY/PS) did not affect the in-
teraction of WASP with SH3 domain containing proteins tested (data
not shown). It is possible that there is more than one binding site for
some of the SH3 domain containing proteins within the proline rich re-
gion of the WASP as well as in other regions of the WASP.
Expression of human WASP and WIP suppressed the growth defect
of las17Δ strain; WASP–WIP interaction and a functional VCA domain
onWASP are essential for suppression of growth defect of las17Δ strain
[36]. In order to analyze the effect of WASP mutants (WASPS339Y,
WASPP373S,WASPSP/YS) on the formation of functionalWIP–WASP com-
plex, plasmids expressing WASP or its mutants were transformed into
las17Δ cells together with either empty plasmid or plasmid expressing
WIP. The transformants were streaked onto YPUAD agar plates and
grown either at 24 °C or 37 °C for 3 days. The WASP-PRR mutants
(WASPS339Y or WASPP373S or WASPSP/YS) did not affect the ability of
WASP to rescue the growth defect of las17Δ strain (Fig. 5A). Western
blot analysis showed equal expression of WTWASP and its mutants inWT
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Fig. 6.WASPS339Ymutation causes a partial open conformation. A) S. cerevisiae cellswere transformedwithWASP sensor (WT,WASPS339Y,WASPP373S,WASPSP/YS) and either empty vector
or plasmid expressing NLS–WIP. The transformants were grown at 24 °C in selective media and YFP signals in these cells were subsequently analyzed using ﬂuorescence microscopy.
Bar = 5 μm. B) Fluorescence signal quantiﬁcation from 100 S. cerevisiae cells transformed with plasmids as described in panel A using MetaMorph software. ***P b 0.001 compared to
WASP sensor + NLS–WIP (unpaired Student's t-test). C) Western blot analysis of expression of WASP in S. cerevisiae transformants (panel A) using anti-GFP antibody and anti-
Hexokinase (loading control).
630 N. Jain et al. / Biochimica et Biophysica Acta 1842 (2014) 623–634las17Δ cells (Fig. 5B). The results indicate that the mutations in the PRR
do not affect the formation of functionalWASP–WIP complex. Most im-
portantly this result shows that the activity of both the N-terminus
WH1 domain and the C-terminus VCA domain of WASP mutants is
still functional.3.6. WASPS339Y and WASPSP/YS missense mutants adopt a partially open
conformation in the presence of WIP
WASPexists in twodifferent conformations, the auto-inhibited closed
conformation which is stabilized by WIP and active open conformation
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WASPP373S and WASPSP/YS) do not affect interaction of WASP with SH3
domain containing proteins (data not shown) and formation of WASP–
WIP complex; however themutationsmight affect changes in the confor-
mation of WASP. To analyze whether the missense mutations
(WASPS339Y or WASPP373S or WASPSP/YS) lead to changes in the confor-
mation of WASPS339Y or WASPP373S or WASPSP/YS, yeast strain PJ69-4A
was transformed with WASP sensor (WT or WASPS339Y or WASPP373S
or WASPSP/YS) together with either NLS–WIP or empty vector. The con-
struction of WASP or WASP-PRR mutant sensor was performed as de-
scribed previously [23]. The transformants were grown to exponential
phase at 24 °C and analyzed using ﬂuorescence microscopy (Fig. 6A).
The YFP ﬂuorescence signals from 100 cells were quantiﬁed and plotted
(Fig. 6B). The YFP ﬂuorescence intensity of WASPS339Y, WASPP373S and
WASPSP/YS sensors was similar to WT WASP sensor in the absence of
WIP. However the YFP ﬂuorescence intensity of all the WASP sensors
was enhanced signiﬁcantly in the presence of WIP suggesting that WIP
stabilizes the closed conformation of all the WASP sensors which is con-
sistent with the previous ﬁndings [23].
The YFP ﬂuorescence intensity of WASPS339Y sensor + WIP or
WASPSP/YS sensor + WIP sensors but not WASPP373S sensor + WIP
was signiﬁcantly reduced compared to WASP sensor + WIP. However,
the ﬂuorescence intensity ofWASPSP/YS sensor orWASPS339Y sensorwas
signiﬁcantly increased in the presence of WIP compared to absence of
WIP indicating that WASPSP/YS and WASPS339Y sensor exists in partially
open conformation (Fig. 6A, B). The reduced ﬂuorescence intensity of
WASPSP/YS sensor could be the effect of WASPS339Y mutation alone as
the YFP ﬂuorescence intensity of WASPP373S sensor was similar to
WASP sensor in the presence of WIP. Western blot analysis showedthe similar expression of all WASP sensors either in the presence or in
the absence of WIP indicating that the increase in ﬂuorescence intensi-
ties of all the WASP sensors in the presence of WIP was not due to in-
creased expression of sensor molecules (Fig. 6C). These results suggest
that WASP-PRR point mutation (serine339 to tyrosine339 of WASP)
S339Y, alters the WASP closed conformation in the presence of WIP.
3.7. Toca-1 and Nck1 further reduced the YFP ﬂuorescence of WASPS339Y
sensor in the presence of WIP
The single mutation WASPS339Y and the double mutant WASPSP/YS
adopt a partial open conformation even in the presence of WIP
(Fig. 6). Toca-1 and Nck1 have been shown to open up the closed con-
formation of WASP [23]. In order to analyze the effect of Toca-1 and
Nck1 on conformational changes of WASPS339Y, yeast cells expressing
WASP sensor/NLS–WIP or WASPS339Y sensor/NLS–WIP were trans-
formed with empty vector or plasmids expressing NLS–Toca-1 or
NLS–Nck1. The transformants were then analyzed using ﬂuorescence
microscopy (Fig. 7A).
Analysis of ﬂuorescence intensity (Fig. 7B) revealed that both Toca-1
and Nck1 further reduced the YFP ﬂuorescence fromWASPS339Y sensor.
The Western blot analysis of WASPS339Y sensor showed its similar ex-
pression in all the respective transformants (Fig. 7C). These results indi-
cate that Toca-1 or Nck1 induces conformational changes of WASPS339Y
sensor suggesting formation of a functional WASPS339Y–Toca-1 or
WASPS339Y–Nck1 complex.
3.8. Toca-1 or Nck1 does not relieve the auto-inhibition ofWASPP373S sensor
WASP and N-WASP are multi-domain proteins which have been
shown to be regulated by a number of other interacting proteins.
Yeast two hybrid assay (data not shown) suggested that WASPP373S
and WASPSP/YS interact with both Toca-1 and Nck1; however it might
affect the formation of functional WASP–Toca-1 or WASP–Nck1 com-
plex. Result from previous section revealed that WASPP373S exists in
closed conformation in the presence of WIP similar to WASP (Fig. 6).
In order to analyze the effect of Toca-1 or Nck1 on conformation
changes, yeast cells expressing WASPP373S sensor and NLS–WIP were
transformed with empty vector or plasmid expressing NLS–Toca-1 or
NLS–Nck1. The transformants were analyzed using ﬂuorescence mi-
croscopy (Fig. 7A). Analysis of ﬂuorescence intensity (Fig. 7B) revealed
that both Toca-1 and Nck1 did not cause a decrease in the ﬂuorescence
intensity of WASPP373S sensor. However, both Toca1 and Nck1 reduced
the ﬂuorescence intensity of WT WASP sensor (Fig. 7). Western blot
analysis showed the similar expression of WASPP373S sensor in all re-
spective co-transformants (Fig. 7C). Taken together these results indi-
cate that both Toca-1 and Nck1 can disrupt the auto-inhibitory loop of
WASP even in the presence ofWIPwhich is consistentwith previous re-
port [23] but fail to relieve the auto-inhibition of WASPP373S mutant.
Toca-1 or Nck1 had no effect on WASPSP/YS sensor suggesting that the
mutation (P373S) may be inhibiting further changes in conformation
of WASPSP/YS sensor by Toca1 or Nck1.
3.9. WASP-PRR mutations decreased the Hck mediated WASP tyrosine
phosphorylation
The SH3 domain of Hck (tyrosine kinase) has been shown to interact
with WASP at the proline rich region resulting in WASP-Tyr291 phos-
phorylation and WASP activation [34]. Therefore, the effect of WASP-
PRR mutants on Hck mediated tyrosine phosphorylation of WASP was
analyzed. HEK293T cells were transfected with WASP-His or WASP-
PRR mutants (WASPS339Y or WASPP373S or WASPSP/YS) tagged with
His-tag together with empty vector or plasmid expressing Hck-GFP.
The cells were lysed 36 h after transfections and His-tag pull-down
assay was performed. The tyrosine-phosphorylation levels of WASP or
WASP-PRR mutants were detected using phosphotyrosine speciﬁc
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still bound to Hck (Fig. 8) which is consistent with yeast two hybrid
assay (data not shown). Quantiﬁcation of Western blots using densi-
tometry analysis revealed thatWASP-PRRmutants had signiﬁcantly re-
duced Hck mediated tyrosine phosphorylation (Fig. 8). No WASP
tyrosine phosphorylation was detectedwhen the cells were transfected
with WASP or WASP-PRR mutants without Hck indicating that the
phosphorylation levels detected in theWestern blots were due to exog-
enous Hck expression. Thus, these results indicate that WASP-PRR mu-
tations either individual or together decreased the HckmediatedWASP
tyrosine phosphorylation.4. Discussion
Wiskott–Aldrich Syndrome is caused by mutations in the gene
encodingWASP, an adaptor protein which regulates the actin cytoskel-
eton by activating the Arp2/3 complex [3]. Majority of the WASP mis-
sense mutations are found in the WH1 domain of WASP [16,17];
which mediates interaction with WIP [6]. We have previously shown
that mutations located outside the WH1 domain of WASP do not affect
the activity of WASP in S. cerevisiae las17Δ strain [19]. Two missense
mutations (S339Y, P373S) in the PRR of WASP have been reported to
occur together in WAS patients; however the molecular defect caused
by these mutations or the contribution of each mutation to the clinical
outcome has not been characterized.
WASP knockdown Jurkat T-cells (JurkatWKD T-cells) are defective in
chemotaxis towards SDF-1 , had reduced migration velocity and are de-
fective in IL2 expression upon activation similar to T-cells fromWAS pa-
tients [31]. JurkatWKD T-cells expressingWASP-PRRmutants (WASPRS339Y,
WASPRP373S, WASPRSP/YS) had migration velocities comparable to cells ex-
pressing WASPR (Fig. 1B). However the mutants were not able to rescue
the chemotaxis defect of JurkatWKD T-cells in both Dunn chamber and
transwell chemotaxis assay (Fig. 1). Actin cytoskeleton rearrangement
to form membrane projections upon stimulation with anti-CD3/anti-
CD28 was also defective in JurkatWKD T-cell expressing WASP-PRR mu-
tants compared to JurkatWKD T-cells expressing WASPR (Fig. 2). Thus
both the mutations either individually or together affect the chemotaxis
and actin cytoskeleton remodeling in T-cells. However the mutations ei-
ther individually or together did not affect the conformation, stability or
activity of the WH1 domain and VCA domain of WASP in regulating the
actin cytoskeleton of S. cerevisiae as all the mutants suppressed the
growth defect of las17Δ cells together with WIP (Fig. 5).
WASP is critical for T-cell activation and IL2 expression upon TCR
stimulation [31]. The PRR of WASP is critical for its localization to T-
cell:APC contact site [25]. Though WASP-PRR mutations did not affect
the interaction of WASP with Nck1 (data not shown), the localization
of WASP-PRR mutants was disrupted (Fig. 3). WASPRS339Y-RFP localized
in the form of small clusters compared to the co-localization of
WASPR-RFP with actin at the cell periphery and T-cell:B cell contact
site. Expression of WASPRS339Y rescued the IL-2 expression defect of
JurkatWKD T-cell (Fig. 4) indicating that WASPRS339Y mutant can form
functional contacts with downstream effectors required for T-cell acti-
vation. The localization of WASPRP373S-RFP was diffused throughout the
spread cell with some co-localization with actin at the cell periphery
(Fig. 3) and this mutant was unable to rescue the IL-2 gene transcription
defect of JurkatWKD T-cells.WASPRSP/YS-RFP behaved similar toWASPRP373S-
RFP in terms of its localization pattern at TCR contact sites and T-cell acti-
vation, suggesting a dominant effect of WASPP373S mutation over the
WASPS339Y mutation (Figs. 3, 4). WASPS339Y mutant was unable to rescue
the chemotaxis but it can rescue the IL-2 gene transcription defect of
JurkatWKD T-cell. This is consistent with earlier reports that the activity
of WASP in regulating actin cytoskeleton is independent of its role in IL2
transcription [37]. Thus our results suggest that Pro373Sermutation abol-
ishes all the activities of WASP in T-cells while Ser339Tyr abolishes only
the actin cytoskeleton regulatory activities of WASP.WASP has been shown to adopt intra-molecular closed conforma-
tion mediated by interaction between GBD and VCA regions of WASP
[22]. This auto-inhibitory closed conformation of WASP has been sug-
gested to be stabilized by interaction with WIP [23,38]. The proline
rich region of WASP has been shown to interact with SH3 domain con-
taining proteins [17], and binding of Toca-1 or Nck1 can relieve this
auto-inhibitory conformation [23]. The mutations (WASPS339Y or
WASPP373S or WASPSP/YS) did not affect the interaction with sixteen
known WASP binding proteins including Toca-1 and Nck1 (data not
shown). It is possible that there is more than one binding site on
WASP for some of these proteins and the point mutations may have af-
fected only one of these binding sites. For instance, the Src kinase Fyn
has been shown to interact with the PRR of WASP [39] and WASP1–170
[40]. All these results suggest that WASP is likely to have more than
one binding sites for interaction with SH3 domain containing proteins.
The conformational analysis of WASP and its mutants using BiFC assay
as described previously [23] revealed that WASPS339Y and WASPSP/YS
sensors adopt partially open conformation compared to WASP and
WASPP373S sensors in the presence of WIP. However, unlike WASP, the
closed conformation of WASPP373S sensor was not altered in the pres-
ence of either Toca-1 or Nck1 (Fig. 7) suggesting that Pro373 is crucial
for conformational change of WASP. In contrast to WASPP373S sensor,
the ﬂuorescence intensity of WASPS339Y was reduced in the presence
of either Toca-1 or Nck1 (Fig. 7). The ﬂuorescence intensity of
WASPSP/YS sensor was not reduced in the presence of Toca1 or Nck1
probably due to the presence of Pro373Ser mutation which does not
allow changes in the conformation of WASP. The altered conformation
of WASP-PRR mutants was neither due to any loss of interaction of
WASP mutants with SH3 domain containing proteins (data not
shown) nor due to loss of interaction with active Cdc42 molecule (Fig.
S2). Thus, the altered conformation ofWASPP373S orWASPSP/YS mutants
may not be responsible for loss of WASP interaction with upstream ac-
tivators (SH3 domain containing protein; data not shown) but it could
be responsible for defects in activation of WASP downstream effectors
essential for IL-2 production. The altered conformation of WASP-PRR
mutants might affect the WASP phosphorylation as WASP mutant
L270P unfolded the WASP molecule and had increased the basal level
of WASP phosphorylation [35]. Phosphorylation of WASP-PRR mutants
was not affected in Jurkat T-cellwhen stimulatedwith anti-CD3/C28 an-
tibodies (Fig. S3). However, these mutations caused signiﬁcant reduc-
tion in Hck mediated tyrosine phosphorylation of WASP in HEK293T
cells (Fig. 8). This difference could be due to the presence of other
WASP regulator in Jurkat T-cells such as Fyn which regulates the
WASP phosphorylation upon TCR stimulation [41] as well as increased
turnover of WT WASP upon phosphorylation [42]. Tyorsine291 phos-
phorylation of WASP has been shown to destabilize the auto-
inhibitory loop formed between the basic region and VCA domain of
WASP and facilitated the binding of Arp2/3 complex and actin polymer-
ization [34,43]. Phosphorylation of WASP has been shown to be impor-
tant for WASP turnover and cell migration as inhibition of WASP
turnover by inhibiting calpain impaired dendritic cell motility [44].
Hck has been shown to phosphorylate WASP upon chemo-attractant
stimuli [45]. Hck mediated tyrosine phosphorylation of WASP-PRRmu-
tations was reduced compared to WT WASP (Fig. 8) indicating critical
effect of both the WASP mutations on Jurkat T-cell motility, thus, caus-
ing defective homing of T-cells and being responsible for WAS. Expres-
sion ofWASP confers a selective advantage for T-cells [46] and a number
of reports have shown that patients with mutations which cause severe
WAS exhibit revertantmosaicismwhere a second-sitemutation leads to
altered but functional gene products [47,48].
We have shown that though WAS patients had two mutations to-
gether, WASPP373S mutation alone compromised all activity of WASP
in T-cells. Proline 373 of WASP is crucial for relieving WASP from the
closed conformation and Pro373Ser mutation abolished the conforma-
tional changes required for the activity of WASP in promoting IL2 ex-
pression and chemotaxis. WASPS339Y mutation compromised only the
634 N. Jain et al. / Biochimica et Biophysica Acta 1842 (2014) 623–634actin cytoskeleton's regulatory role of WASP without affecting WASP
role in IL2 transcription and the WASPS339Y mutant adopted a partial
opened conformation. This mutation in the double mutants allowed
WASPSP/YS to adopt a partial open conformation and probably reduces
the severity of the clinical symptoms.
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